Создание гуманизированных мышей для фармакотоксикологических исследований (успехи, неудачи и перспективы)
Н. Н. Каркищенко, В П Рябых, В. Н. Каркищенко et al. · Биомедицина · 2014
Analysis of successes and failures in obtaining transgenic mice with integrated human Nat genes and CYP3A4, based on the literature data and the results of our own research to use them as biomodels when tested pharmacological efficacy and toxicity of drugs. The analysis of possible causes of failure in obtaining transgenic mice with increased expression of human genes Nat1, Nat2, and CYP3A4, transmitting the transgene inheritance and humanized mice were done. The importance of the role of the promoter in the creation of genetically engineered structures discusses. Its own evidence that to obtain transgenic animals by microinjection method gene constructs into the zygotes pronucleus little different variants cytomegalovirus promoter (cmv). This cmv-promoter starts to include uncontrolled transgene expression at very early stages of embryo development, which often leads to his death provides. The possibility to obtain lines of humanized mice with integrated human genes Nat1 and Nat2 and a very low level of activity of endogenous Nat2 without using mice with knockout genes, Nat1 and Nat2 for crossing with transgenic mice. The analysis of our own results and causes of failures in obtaining of transgenic animals helped to get us humanized mice with integrated Nat1 and Nat2 genes, providing specific transgenes expression and create DNA-construction for animals with CYP3A4 gene.
Cited by 0 works.